CA
ABBV icon

Cornerstone Advisory’s AbbVie ABBV Stock Holding History

Cornerstone Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Buy
16,202
+152
+0.9% +$32.7K 0.34% 54
2026
Q1 		$3.49M Buy
16,050
+73
+0.5% +$16.2K 0.33% 55
2025
Q4 		$3.65M Buy
15,977
+135
+0.9% +$30.8K 0.35% 54
2025
Q3 		$3.67M Buy
15,842
+258
+2% +$52.5K 0.36% 53
2025
Q2 		$2.89M Sell
15,584
-22
-0.1% -$4.09K 0.31% 54
2025
Q1 		$2.92M Sell
15,606
-210
-1% -$40.8K 0.34% 53
2024
Q4 		$3.05M Buy
15,816
+230
+1% +$42.3K 0.35% 53
2024
Q3 		$3.08M Sell
15,586
-401
-3% -$74.8K 0.41% 52
2024
Q2 		$2.74M Sell
15,987
-5,137
-24% -$851K 0.39% 52
2024
Q1 		$3.85M Buy
21,124
+16
+0.1% +$2.76K 0.55% 44
2023
Q4 		$3.27M Buy
21,108
+795
+4% +$116K 0.51% 44
2023
Q3 		$3.03M Buy
20,313
+94
+0.5% +$13.8K 0.53% 40
2023
Q2 		$2.72M Sell
20,219
-244
-1% -$35.8K 0.48% 42
2023
Q1 		$3.26M Buy
20,463
+1,798
+10% +$275K 0.59% 34
2022
Q4 		$3.02M Sell
18,665
-1,495
-7% -$229K 0.59% 36
2022
Q3 		$2.71M Buy
20,160
+2,281
+13% +$327K 0.6% 34
2022
Q2 		$2.74M Sell
17,879
-14,850
-45% -$2.27M 0.63% 34
2022
Q1 		$5.31M Sell
32,729
-6
-0% -$872 0.81% 26
2021
Q4 		$4.43M Sell
32,735
-73
-0.2% -$8.62K 0.64% 30
2021
Q3 		$3.54M Sell
32,808
-619
-2% -$70.7K 0.59% 35
2021
Q2 		$3.77M Buy
33,427
+3,384
+11% +$381K 0.63% 35
2021
Q1 		$3.25M Sell
30,043
-1,881
-6% -$201K 0.62% 35
2020
Q4 		$3.42M Buy
31,924
+1,271
+4% +$122K 0.69% 36
2020
Q3 		$2.69M Buy
30,653
+19,374
+172% +$1.82M 0.63% 41
2020
Q2 		$1.11M Buy
11,279
+5,927
+111% +$522K 0.29% 65
2020
Q1 		$408K Buy
+5,352
New +$456K 0.12% 104

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Cornerstone Advisory's ABBV Position: Q2 2026 in Review

Cornerstone Advisory increased its AbbVie (ABBV) stake by 0.95% in Q2 2026, buying an estimated $32.7K and bringing the position to 16,202 shares worth $4.08M. The position accounts for 0.34% of the portfolio, ranked #54.

Cornerstone Advisory first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.31M in Q1 2022. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cornerstone Advisory held 16,202 shares of AbbVie worth $4.08M as of Q2 2026.
  • Cornerstone Advisory bought 152 AbbVie shares in Q2 2026, an estimated $32.7K.
  • AbbVie made up 0.34% of Cornerstone Advisory's portfolio in Q2 2026, its #54 holding.
  • Cornerstone Advisory first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • Cornerstone Advisory's AbbVie position peaked at $5.31M in Q1 2022.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.